Insulet Corp. (PODD)

147.48 -3.10 (-2.06%) USD  |  NASDAQ  |  Sep 04, 16:00
147.43 -0.05 (-0.03%) After-Hours: 20:00
More

Insulet SG&A Expense (TTM) : 1.309B for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PODD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 1.309B
March 31, 2026 1.222B
December 31, 2025 1.165B
September 30, 2025 1.094B
June 30, 2025 1.013B
March 31, 2025 978.10M
December 31, 2024 917.20M
September 30, 2024 869.00M
June 30, 2024 815.60M
March 31, 2024 771.90M
December 31, 2023 734.90M
September 30, 2023 666.40M
June 30, 2023 626.10M
March 31, 2023 621.80M
December 31, 2022 587.80M
September 30, 2022 565.20M
June 30, 2022 542.30M
March 31, 2022 484.20M
December 31, 2021 466.00M
September 30, 2021 474.40M
June 30, 2021 446.10M
March 31, 2021 410.60M
December 31, 2020 384.00M
September 30, 2020 335.10M
June 30, 2020 321.20M
Date Value
March 31, 2020 316.95M
December 31, 2019 300.52M
September 30, 2019 284.89M
June 30, 2019 282.94M
March 31, 2019 265.71M
December 31, 2018 253.78M
September 30, 2018 249.71M
June 30, 2018 227.81M
March 31, 2018 218.45M
December 31, 2017 210.10M
September 30, 2017 197.65M
June 30, 2017 185.70M
March 31, 2017 174.52M
December 31, 2016 166.08M
September 30, 2016 117.04M
June 30, 2016 113.88M
March 31, 2016 109.76M
December 31, 2015 104.23M
September 30, 2015 135.87M
June 30, 2015 133.30M
March 31, 2015 133.00M
December 31, 2014 127.68M
September 30, 2014 122.43M
June 30, 2014 127.61M
March 31, 2014 120.72M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
DexCom, Inc. 1.361B
Abbott Laboratories 13.94B
Boston Scientific Corp. 7.159B
PROCEPT BioRobotics Corp. 252.06M
Globus Medical, Inc. 1.217B